导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -12.19% | 860/1050 |
| 近一周 | -2.72% | 704/1104 |
| 近一月 | -2.94% | 341/1102 |
| 近一季 | 0.35% | 232/1092 |
| 近半年 | -10.07% | 763/1070 |
| 近一年 | -5.44% | 658/1018 |
| 近两年 | 9.82% | 839/926 |
| 近三年 | 12.81% | 571/834 |
| 成立以来 | 186.00% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.89% 948/1070 |
-5.08% 797/1101 |
- - |
- - |
| 2025 | 17.39% 715/1065 |
0.40% 766/1014 |
3.95% 365/1038 |
6.45% 910/1050 |
5.66% 114/1065 |
| 2024 | 14.08% 196/1011 |
11.16% 18/960 |
4.94% 97/983 |
2.31% 931/991 |
-4.41% 625/1011 |
| 2023 | -6.26% 233/952 |
3.26% 424/880 |
-3.32% 403/895 |
-2.23% 163/915 |
-3.95% 404/952 |
| 2022 | -17.09% 225/867 |
-11.05% 128/773 |
0.48% 686/806 |
-8.79% 187/845 |
1.70% 338/867 |
| 2021 | 9.20% 260/740 |
0.23% 143/580 |
3.83% 486/659 |
-1.38% 242/704 |
6.39% 165/740 |
| 2020 | 62.18% 182/554 |
-6.23% 324/419 |
22.68% 231/466 |
21.77% 42/517 |
15.77% 189/554 |
| 2019 | 37.81% 235/410 |
17.26% 971/1149 |
4.36% 60/1231 |
2.41% 269/390 |
9.97% 160/410 |
| 2018 | -16.75% 39/349 |
- - |
- - |
- - |
-10.48% 327/1080 |
| 2017 | 30.17% 41/285 |
- - |
- - |
- - |
- - |
| 2016 | 4.62% 18/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 工银新蓝筹股票A VS. 东吴新产业精选股票A(580008) |